학술논문

A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system.
Document Type
journal article
Source
Pediatric Blood & Cancer; Sep2018, Vol. 65 Issue 9, p1-1, 10p
Subject
Language
ISSN
15455009